ReproCELL Incorporated (4978) Stock Overview

ReproCELL Incorporated provides stem cell research services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides genomics, clinical stem cell research, preclinical drug discovery CRO, human tissue samples, clinical laboratory, diagnostic, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.